Child Abuse and Prevention Month in Pharr

Translate to Spanish or other 102 languages!

The Pharr City Commission declared April 2025 as Child Abuse and Prevention Month, affirming the city’s commitment to safeguarding children and supporting families. Image courtesy of The City of Pharr
The Pharr City Commission declared April 2025 as Child Abuse and Prevention Month, affirming the city’s commitment to safeguarding children and supporting families. Image courtesy of The City of Pharr
- Advertisement -

The Pharr City Commission declared April 2025 as Child Abuse and Prevention Month, affirming the city’s commitment to safeguarding children and supporting families. The proclamation emphasizes that children are among our most valuable and vulnerable assets, and that ensuring their safety, stability, and nurturing environment is a shared responsibility across the community. 

Danny Ramirez, Pharr EMS Chief, accepted the proclamation alongside members of his command staff and representatives from Driscoll Children’s Hospital, including Dr. Maryann Alvarez Griffis, the Rio Grande Valley’s first pediatric child abuse physician. “We thought it was important to partner with Driscoll Children’s Hospital in honor of the proclamation, as it allows us to not only recognize their invaluable work but also shed light on their ongoing efforts to help combat child abuse in our community,” said Ramirez. 

Through this proclamation, the City of Pharr reinforces its dedication to creating a strong network of support among citizens, agencies, and institutions to prevent child abuse and ensure every child has the opportunity to grow and thrive.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -